Index test:68Ga-Pentixafor PET/CT

3 trials

Sponsors

Peking University First Hospital, West China Hospital of Sichuan University, The First Affiliated Hospital of Chongqing Medical University

Conditions

Chemokine Receptor 4–Targeted 68Ga-Pentixafor PET/CT in differentiated thyroid cancerTumors with High CXCR4 Expressionprimary aldosteronism

Unknown Phase

Diagnostic value of 68Ga pentixafor PET / CT adrenal imaging in the diagnose and typing of primary aldosteronism

RecruitingChiCTR2300073049

Peking University First Hospitalprimary aldosteronism

Start: 2022-08-31Updated: 2023-07-02

Chemokine Receptor 4–Targeted 68Ga-Pentixafor PET/CT in differentiated thyroid cancer

RecruitingChiCTR2400084339

West China Hospital of Sichuan UniversityChemokine Receptor 4–Targeted 68Ga-Pentixafor PET/CT in differentiated thyroid cancer

Start: 2023-09-14Updated: 2024-05-21

Tumor PET imaging technology targeting chemokine receptor 4

Active, not recruitingChiCTR2600121072

The First Affiliated Hospital of Chongqing Medical UniversityTumors with High CXCR4 Expression

Start: 2026-04-01Updated: 2026-03-30

Related Papers

<sup>68</sup>Ga-pentixafor PET/CT Is a Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling.

2024-12-233 citations